PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 18, 20260 citationsOpen Access

Parkinson's Disease as a Potential Stuck Program Mode of the Candida albicans Biochemical Computer

View Full Paper
CJCraddock Jim

Key Points

  • To explore the idea that Parkinson's disease may be driven by Candida albicans affecting dopaminergic neurons through biochemical pathways.
  • Application of the biochemical computer framework to Parkinson's disease.
  • Analysis of gut-brain axis interactions in PD.
  • Identification of potential neurotoxic metabolites involved in PD pathogenesis.
  • Proposed link between Candida albicans and Parkinson's disease as a stuck program mode.
  • Noted neurotoxic production via the kynurenine pathway affecting dopaminergic neurons.
  • Highlighted gaps in evidence needed to support the proposal.

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra, producing motor symptoms (tremor, rigidity, bradykinesia) and non-motor symptoms (constipation, depression, cognitive decline, anosmia) that often precede motor onset by decades. The non-motor prodrome, particularly the gastrointestinal symptoms, has led to increasing interest in the gut-brain axis as a contributor to PD pathogenesis. This paper applies the biochemical computer framework (Craddock, 2026a; 2026b) to propose, speculatively, that PD may represent a stuck program mode in which the commensal fungal symbiont Candida albicans drives sustained dopaminergic interface engagement and neurotoxic kynurenine pathway metabolite production, resulting in progressive burnout of substantia nigra neurons. A program refined for Homo Candidus with a likely limited duration, but in this case stuck without an exit due to version conflict. This candidate is explicitly presented as a speculative extension of the framework. The mechanistic chain requires more intermediary steps than the other conditions in this series, and the clustering evidence is the weakest of any candidate. The paper is included to demonstrate the framework's range, to generate testable hypotheses, and to identify the specific evidentiary gaps that would need to be filled to strengthen or reject the proposal.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Craddock Jim (2026) studied this question.

synapsesocial.com/papers/69e320af40886becb653fd4fhttps://doi.org/10.5281/zenodo.19600888
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Gut Microbiota in Parkinson’s Disease: Mechanistic Insights into Microbial–Host Interactions2026 · 1 citations
  2. 2Parkinson's Disease as a Multiscale Dopaminergic-Ionic-Bioenergetic Disorder2026
  3. 3Alzheimer's Disease Through the Symbiont Lens: Candida albicans, Amyloid as Defensive Encapsulation, and the SOX9-MEGF10-Hk1 Astrocyte Triad2026
  4. 4Integrated Mechanisms Driving Parkinson's Disease Pathogenesis2026 · 1 citations
  5. 5Parkinson's Disease: Molecular Mechanisms, Metabolic Interactions, Biomarkers, and Emerging Therapeutic Targets2026